Abstract
Optimization of a series of aminomethyl ketone diamine H(3)R antagonists to reduce the brain exposure by lowering the pKa, led to molecules with improved pharmacokinetic properties. Compounds 9, 19, and 25 had high affinity for human H(3)R and demonstrated in vivo H(3)R functional activity in the rat dipsogenia model. Compound 9 displayed modest wake-promoting activity in the rat EEG/EMG model.
Copyright © 2012 Elsevier Ltd. All rights reserved.
MeSH terms
-
1-Propanol / chemistry
-
1-Propanol / pharmacology
-
Animals
-
Drug Inverse Agonism*
-
Histamine Agonists* / chemistry
-
Histamine Agonists* / pharmacology
-
Humans
-
Ketones / chemistry*
-
Ketones / pharmacology
-
Methylamines / chemistry
-
Methylamines / pharmacology
-
Phenols / chemistry
-
Phenols / pharmacology
-
Pyrrolidines / chemistry
-
Pyrrolidines / pharmacology
-
Rats
-
Sleep Disorders, Circadian Rhythm / drug therapy
-
Wakefulness / drug effects*
Substances
-
Histamine Agonists
-
Ketones
-
Methylamines
-
Phenols
-
Pyrrolidines
-
phenoxy radical
-
1-Propanol
-
methylamine
-
pyrrolidine